Thyroid cancer
Conditions
Interventions
RD group:0.2% Ropivacaine injection + Dexmedetomidine 0.5 µg/kg, total 6 ml, used for right-sided stellate ganglion block
R group:0.2% Ropivacaine Injection 6ml for Right Stellate Ganglion Block
Sponsors
Liu'an People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients scheduled for elective radical thyroidectomy for thyroid cancer under general anesthesia; 2.ASA physical status I or II; 3.Age 18-65 years, with no communication barriers, able to complete various assessments independently; 4.BMI < 32 kg/m²; 5.Agree to participate in this study and sign the "Informed Consent Form."
Exclusion criteria
Exclusion criteria: 1.Severe hypertension, severe arrhythmia, severe cardiac or cerebral dysfunction, or renal impairment; 2.Allergy to dexmedetomidine or ropivacaine; 3.Cognitive impairment, hearing impairment, language disorders, history of psychiatric illness, or difficulty in communication or cooperation due to mental disorders; 4.Pregnancy or breastfeeding; 5.Refusal to participate in this study.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and Depression Scale Score;Visual Analog Scale Scoring;Hemodynamic Parameters (MAP, HR, SpO2);Incidence of Adverse Events; | — |
Primary
| Measure | Time frame |
|---|---|
| Actigraphy Sleep Data;Insomnia Severity Index Score; | — |
Countries
China
Contacts
Public ContactCheng Feng
Liu'an People's Hospital
Outcome results
None listed